Skip to main content
AXGN logo

Axogen, Inc.

AXGNNASDAQHealthcareMedical Devices

$34.61Today:- (-)1Y +114.77%

As of Oct 16, 2026 close

Market cap
$1.90B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$15.94$52.91
Volume (live)
-
Avg. volume (3M)
1.46M

Axogen (AXGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Axogen reported total assets of $221.69M and total liabilities of $92.84M. Shareholders' equity was $128.85M, up 24.0% from $103.91M a year earlier. Total debt stood at $67.63M against $35.55M in cash and short-term investments, a net debt position of $32.08M. That puts debt-to-equity at 0.52, compared with 0.48 a year earlier.

Axogen Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Axogen, Inc. (AXGN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents35.5527.5531.0215.2832.7648.7735.7224.2936.51
Short-Term Investments0.005.930.0033.5151.3355.2060.7992.310.00
Cash & Short-Term Investments35.5533.4831.0248.7984.09103.9796.51116.6136.51
Accounts Receivable26.1724.1125.1522.1918.1617.6216.9415.3211.06
Inventory42.3733.1823.0218.9116.6912.5313.8611.987.32
Other Current Assets16.338.452.818.208.114.057.717.051.71
Total Current Assets120.4299.2288.0098.08127.05145.25135.02150.9555.74
Non-Current Assets
Property, Plant & Equipment (Net)94.5298.93104.2993.6678.1254.0818.118.042.20
Intangible Assets6.755.584.533.652.862.051.521.180.94
Other Non-Current Assets0.000.000.000.000.000.000.000.000.00
Total Non-Current Assets101.27104.51108.8297.3180.9856.1319.629.223.13
Total Assets221.69203.73196.83195.39208.02201.38154.64160.1758.87
Current Liabilities
Accounts Payable2.8928.6411.7722.445.924.608.264.523.24
Short-Term Debt2.371.971.551.313.670.861.740.036.91
Accrued Liabilities1.6720.633.1813.486.8617.37---
Deferred Revenue0.000.000.000.000.000.000.010.020.03
Other Current Liabilities18.3020.6317.1113.4814.7017.3710.878.489.71
Total Current Liabilities23.5630.6130.4323.7524.2922.8320.8813.0413.72
Non-Current Liabilities
Long-Term Debt65.2647.5046.6045.7165.6234.523.190.0419.91
Deferred Tax Liabilities0.000.000.000.000.000.000.000.00-0.16
Other Non-Current Liabilities4.032.492.994.525.560.00-1.600.070.00
Total Non-Current Liabilities69.2869.2170.7370.6471.1855.401.610.1519.97
Total Liabilities92.8499.82101.1694.3995.4778.2322.4913.1933.69
Stockholders' Equity
Common Stock0.470.440.430.420.420.410.400.390.34
Retained Earnings-306.96-291.26-281.30-259.58-230.63-203.65-179.86-150.73-128.33
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00-2.86-2.29
Additional Paid-in Capital435.34394.73376.53360.16342.77326.39311.62297.32153.17
Shares Outstanding47.2044.1543.1242.4541.74----
Total Stockholders' Equity128.85103.9195.67101.00112.55123.15132.15146.9825.18
Total Liabilities & Equity221.69203.73196.83195.39208.02201.38154.64160.1758.87

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Axogen Balance Sheet

How much debt does Axogen have?

Axogen had total debt of $67.63M as of Dec 31, 2025, against $35.55M in cash and short-term investments. Its debt-to-equity ratio was 0.52. Total debt was $49.47M a year earlier.

What are Axogen's total assets?

Axogen reported total assets of $221.69M as of Dec 31, 2025, up 8.8% from $203.73M a year earlier. Total liabilities were $92.84M.

What is Axogen's shareholders' equity?

Axogen's shareholders' equity was $128.85M as of Dec 31, 2025, or about $2.73 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition